The RHAPSODY Consortium

The consortium groups 20 academic research laboratories focused especially on diabetes research (including 3 university hospitals with extensive experience following long-term diabetes cohorts and biobank), two SMEs (one specialised in lipid analyses and the other in scientific project management) and four well-established pharmaceutical and biotechnology establishments, all part of the European Federation of Pharmaceutical Industries and Associations (EFPIA).

Bringing together the expertise of all these groups is certain to provide the means to achieve the goals of RHAPSODY.
Stacks Image p7483_n47
Stacks Image p7483_n398
Stacks Image p7483_n51
Stacks Image p7483_n349
This project receives funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 115881. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.

This work is supported by the Swiss State Secretariat for Education‚ Research and Innovation (SERI) under contract number 16.0097-2.

The opinions expressed and arguments employed herein do not necessarily reflect the official views of these funding bodies.